The product, which will be called Annovera, won’t be available until the end of 2019 or early in 2020, in addition to also also the item’s not clear yet how much the item will cost. However, the item’s a hormonal contraceptive, so, like different contraceptives, the item uses a combination of female hormones such as progestin in addition to also also estrogen to suppress ovulation in addition to also also help prevent pregnancy.
The flexible, doughnut-shaped ring will be placed inside the vagina for three weeks, in addition to also also then the item’s removed, washed, in addition to also also stored in a case for one week.
This particular cycle will be repeated every four weeks for one year, which translates to 13 menstrual cycles of 28 days each per year. different contraceptive rings, like NuvaRing, are replaced every month.
Annovera can be inserted in addition to also also removed by the woman herself. When removed, the user may experience a period.
The nonprofit organization which developed the ring, the Population Council, recently announced a licensing deal with the pharmaceutical company TherapeuticsMD to market the ring.
The ring will be sold at a discount to federally designated Title X family planning clinics serving lower-income women, a Population Council spokesperson told BuzzFeed News.
“Nearly 9 in 10 women (89%) surveyed were satisfied with the item as a method of contraception,” according to a Population Council statement. “Most participants surveyed experienced no change in sexual pleasure or frequency of sexual intercourse.”
The progestin inside the device will be a completely new type, called segesterone acetate, although the estrogen will be similar to which found in different contraceptives, they said. Like different forms of hormonal birth control, the item does not protect against HIV or different sexually transmitted infections.
Women over age 35 who smoke should not use Annovera, as the item increases the risk of serious cardiovascular events, according to the FDA.
Also, women with certain conditions should avoid This particular product. which includes anyone who will be at high risk of blood clots or related conditions; who includes a history of breast cancer, certain liver conditions, abnormal uterine bleeding; or who will be using certain medications to treat hepatitis C.
As for side effects, they are similar to different hormonal contraceptive products, such as headaches, migraine, nausea, vomiting, yeast infections, abdominal pain, painful menstruation, breast tenderness, irregular bleeding, diarrhea, in addition to also also genital itching.
the item’s unlikely which you will get pregnant if you are using Annovera, although as with different types of birth control, the item will be possible.
Based on clinical trials, the FDA said about 2 to 4 women out of every 100 may get pregnant during the first year they use Annovera. In comparison, there are 18 or more pregnancies a year per 100 women using condoms or the withdrawal method; 6 to 12 per 100 with the pill, a patch, or diaphragms; in addition to also also less than 1 per 100 per year for IUDs or sterilization, according to the Centers for Disease Control in addition to also also Prevention.
The FDA said there will be ongoing monitoring to watch for risks of blood clots in people who use the ring, in addition to also also to see if there are any problems related to the use of different medications or tampons.
“The FDA will be committed to supporting innovation in women’s health in addition to also also today’s approval builds on available birth control options,” according to a statement via Dr. Victor Crentsil, acting deputy director of the Office of Drug Evaluation III in FDA’s Center for Drug Evaluation in addition to also also Research.